1. Home
  2. Will remain in Syria until final victory: Hezbollah

Will remain in Syria until final victory: Hezbollah

[email protected] (Agencies)
October 24, 2016

Lebanon, Oct 24: The secretary general of the Lebanese Hezbollah resistance movement says the group's fighters will remain in neighboring Syria until they achieve the final victory over foreign-sponsored Takfiri terrorists and purge the crisis-hit Arab country of extremists.

HezbollahAddressing people in a speech marking a week since the killing of the movement's military commander, Hatem Hamade, in Syria, Seyyed Hassan Nasrallah dispelled illusions about Hezbollah forces' withdrawing from Syria, stressing that the fighters will leave Syria only after they have defeated Takfiri terrorists there.

"Our choice of going to Syria was very well studied after observing the regional developments that began in Tunisia and reached Syria," he said, adding, "Time has revealed that the battle in Syria is aimed at making existential changes on the ground as well as to the political map of the region."

“We will continue this battle until the end, and we are proud of our martyrs in Syria, and whoever bargains on our tiredness will lose,” he said, emphasizing that the security “we are living in now is not the outcome of agreements or mere prayers," but it is the outcome of efforts made by martyrs and their blood.

Nasrallah pointed out that Hezbollah fighters were not ordered by any third party to play a role in Syria, but rather entered the neighboring country following a comprehensive and extensive analysis.

The Hezbollah leader stated that the ongoing foreign-backed militancy in Syria is not simply aimed at toppling the incumbent Damascus government, but rather meant to make changes to demographic map and borders of the region in order to uproot certain groups of people.

The Hezbollah secretary general further condemned Saudi Arabia as the country actively supporting and financing the Daesh Takfiri terrorists group.

He added that leaded private emails related to former US secretary of state and Democratic presidential candidate, Hillary Clinton, attest to the fact that Saudi Arabia and US were behind forming Daesh group.

Nasrallah also condemned the inaction and passivity of international human rights bodies toward crimes being perpetrated by Daesh terrorists in Iraq and Syria, noting that despite hundreds and thousands of people have been either beheaded or killed in other ways by this group, world rights bodies maintain their silence toward its crimes.

Yemen blockade threatening over 20 million people

Turning to the Saudi-led coalitions' aerial and naval blockade of Yemen, Nasrallah stated that the restrictive measures adopted by Riyadh toward its impoverished southern neighbor have affected the lives of more than 20 million people.

Nasrallah also took to task international organizations for their failure to adopt any decisive measure to end Saudi Arabia's brutal embargo on the Yemeni people.

All Iraqis fighting Daesh to liberate Mosul

Elsewhere in his speech, the Hezbollah secretary general said that people from all walks of life are currently fighting the Daesh Takfiri terrorists in Iraq, and dozens or even hundreds of people are sacrificing their lives in order to liberate the northern Iraqi city of Mosul from Daesh terrorists.

“Unfortunately, what Daesh is doing is under the name of [Prophet] Mohammad (PBUH). They want to throw this name, which has always shined in this world with glory, into darkness of Daesh,” Nasrallah said, adding that committing crimes under the name of Islam and its prophet is a deliberated and preplanned act by Daesh.

The secretary general of Hezbollah also slammed Turkish authorities' for their effort to pave the way for Turkish military to play a role in the operation for the liberation of Mosul, saying that they have a greedy eye on that area of the Iraqi territory.

Hezbollah endorses Aoun for Lebanon president

Elsewhere in his speech, Nasrallah focused on internal issues of Lebanon, including election of the country's new president.

The secretary general of Hezbollah praised former Lebanese prime minister, Saad Hariri, for his endorsement of the founder of Michel Aoun for presidency, emphasizing that the move paves the way for holding presidential election in a realistic manner.

In a televised news conference on Thursday, Hariri, who leads Lebanon's March 14 Alliance, voiced support for his rival, raising hopes for the settlement of a long-running deadlock on Lebanon's political stage.

"I announce today before you my decision to endorse the candidacy of General Michel Aoun for the presidency of the republic," Hariri said, adding that his decision "comes from the need to protect Lebanon and the state and the people."

Aoun, the founder of the Free Patriotic Movement, is an ally of the Lebanese resistance bloc, Hezbollah.

Nasrallah added, “Everything can be solved through dialogue. We do not impose any decision on our allies. Each of us has his own approach.”

Nasrallah emphasized that Hezbollah's members of parliament would vote for Aoun to become president of Lebanon at a parliamentary session at the end of October.

Lebanon has been without a head of state since 2014, when the term of President Michel Suleiman expired.

The Lebanese parliament has repeatedly failed to elect a president due to the lack of quorum. The presidential election has been put off until the end of October.

Under Lebanon's power-sharing system, the president must be a Christian, the prime minister a Sunni Muslim and the parliament speaker a Shia Muslim.

Lebanon's resistance movement Hezbollah has accused Saudi Arabia of thwarting political initiatives and blocking the election of a president in Lebanon.

Hezbollah has strong relations with Amal

In another part of his speech, leader of the Lebanese Hezbollah noted that the movement has strong and deep-seated relations with the Amal (Hope) Movement, and that relationship cannot be disturbed with fabrications.

“We are honest and faithful to our allies and all we seek is to have a secure country,” Nasrallah said.

Comments

Add new comment

About text formats
  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
May 19,2020

May 19: A Chinese laboratory has been developing a drug it believes has the power to bring the coronavirus pandemic to a halt.

The outbreak first emerged in China late last year before spreading across the world, prompting an international race to find treatments and vaccines.

A drug being tested by scientists at China's prestigious Peking University could not only shorten the recovery time for those infected, but even offer short-term immunity from the virus, researchers say.

Sunney Xie, director of the university's Beijing Advanced Innovation Center for Genomics, told AFP that the drug has been successful at the animal testing stage.

"When we injected neutralising antibodies into infected mice, after five days the viral load was reduced by a factor of 2,500," said Xie.

"That means this potential drug has (a) therapeutic effect."

The drug uses neutralising antibodies -- produced by the human immune system to prevent the virus infecting cells -- which Xie's team isolated from the blood of 60 recovered patients.

A study on the team's research, published Sunday in the scientific journal Cell, suggests that using the antibodies provides a potential "cure" for the disease and shortens recovery time.

Xie said his team had been working "day and night" searching for the antibody.

"Our expertise is single-cell genomics rather than immunology or virology. When we realised that the single-cell genomic approach can effectively find the neutralising antibody we were thrilled."

He added that the drug should be ready for use later this year and in time for any potential winter outbreak of the virus, which has infected 4.8 million people around the world and killed more than 315,000.

"Planning for the clinical trial is underway," said Xie, adding it will be carried out in Australia and other countries since cases have dwindled in China, offering fewer human guinea pigs for testing.

"The hope is these neutralised antibodies can become a specialised drug that would stop the pandemic," he said.

China already has five potential coronavirus vaccines at the human trial stage, a health official said last week.

But the World Health Organization has warned that developing a vaccine could take 12 to 18 months.

Scientists have also pointed to the potential benefits of plasma -- a blood fluid -- from recovered individuals who have developed antibodies to the virus enabling the body's defences to attack it.

More than 700 patients have received plasma therapy in China, a process which authorities said showed "very good therapeutic effects".

"However, it (plasma) is limited in supply," Xie said, noting that the 14 neutralising antibodies used in their drug could be put into mass production quickly.

Using antibodies in drug treatments is not a new approach, and it has been successful in treating several other viruses such as HIV, Ebola and Middle East Respiratory Syndrome (MERS).

Xie said his researchers had "an early start" since the outbreak started in China before spreading to other countries.

Ebola drug Remdesivir was considered a hopeful early treatment for COVID-19 -- clinical trials in the US showed it shortened the recovery time in some patients by a third -- but the difference in mortality rate was not significant.

The new drug could even offer short-term protection against the virus.

The study showed that if the neutralising antibody was injected before the mice were infected with the virus, the mice stayed free of infection and no virus was detected.

This may offer temporary protection for medical workers for a few weeks, which Xie said they are hoping to "extend to a few months".

More than 100 vaccines for COVID-19 are in the works globally, but as the process of vaccine development is more demanding, Xie is hoping that the new drug could be a faster and more efficient way to stop the global march of the coronavirus.

"We would be able to stop the pandemic with an effective drug, even without a vaccine," he said.

Comments

Add new comment

About text formats
  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
July 29,2020

If everything goes as Russia’s expectation, it will be world’s first country to approve a coronavirus vaccine for widespread in the second week of August despite safety and efficacy concerns, according to a report. The adenoviral vector-based vaccine developed by Russian military and government researchers is currently in phase 2 trials.

According to a report from CNN, Russian officials are hoping to get approval for the COVID-19 vaccine developed by the Moscow-based Gamaleya Institute on Agust 10 or even before that. The officials told the outlet that the vaccine will be approved for public use with frontline healthcare workers receiving it first.

“It’s a Sputnik moment,” said Kirill Dmitriev, head of Russia’s sovereign wealth fund, which is financing Russian vaccine research, referring to the successful 1957 launch of the world’s first satellite by the Soviet Union, according to CNN.

“Americans were surprised when they heard Sputnik’s beeping. It’s the same with this vaccine. Russia will have got there first,” he was quoted as saying.

However, Russia is yet to release the scientific data on its coronavirus vaccine trials, hence, questions remain about the safety and efficacy of the vaccine, said the report. The vaccine is in the second phase of testing with developers planning to launch the phase 3 trials sometime after August 3.

Earlier, Interfax reported, citing Health Minister Mikhail Murashko, that the vaccine will be widely used in parallel with phase 3 trials. He said the country plans to vaccinate medics who are at high-risk for COVID-19 next month before clinical trials are completed.

Murashko added that individuals at higher risk of getting infected with the coronavirus such as older people or those with health conditions will also be prioritised for the vaccine, although he did not estimate or reveal when that would happen. The minister added 800 people will be recruited for the phase 3 trials.

Meanwhile, health officials were more cautious considering the fact that human testing of the vaccine is incomplete, and the state registration is expected to begin after August 3, reported The Moscow Times.

On Monday, Moderna and Pfizer announced the commencement of the final phase 3 trials of their candidate vaccines against the SARS-CoV-2 virus, which has so far claimed at least 654,477 lives and infected 16,514,500 people worldwide. 

Researchers will recruit up to 30,000 volunteers in separate trials both backed by the US government. India's first indigenous coronavirus vaccine, COVAXIN, is undergoing phase 1 human clinical trials across the country. More than 150 COVID-19 vaccines are being developed all over the world with at least six candidates already in late-stage clinical trials.

Comments

Add new comment

About text formats
  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
August 1,2020

Mexico City, Aug 1: The number of people, who have died of COVID-19 in Mexico, has risen by 688 to 46,688 within the past 24 hours, Deputy Health Minister Hugo Lopez-Gatell said.

The number of victims in Mexico is now higher than in the United Kingdom, where 46,119 people have died of the disease. The largest number of fatalities - 153,311 - has been recorded in the United States, while Brazil comes second with 92,475 deaths.

Lopez-Gatell also said on late Friday that the number of confirmed coronavirus cases had increased by 8,458 to 424,637 over the past day.

A day earlier, the Latin American nation recorded 7,730 new cases of the coronavirus, with 639 fatalities.

The World Health Organisation (WHO) declared the COVID-19 outbreak a pandemic on March 11. To date, over 17.5 million people have been infected with the coronavirus worldwide, with over 677,000 fatalities, according to Johns Hopkins University.

Comments

Add new comment

About text formats
  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.